Search Results - "Labrie F"

This result is not displayed to guests.
Login for full access.

Corticotropin-releasing factor stimulates accumulation of adenosine 3',5'-monophosphate in rat pituitary corticotrophs.

Authors: Labrie, F.

Source: Science; May 28 1982, Vol. 216, p1007-1008, 2p

This result is not displayed to guests.
Login for full access.

Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner.

Authors: Labrie, F. Montesino, M. Archer, D. F. et al.

Source: Climacteric. Dec2015, Vol. 18 Issue 6, p817-825. 9p.

Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy.

Authors: Bouchard, C. Labrie, F. Archer, D. F. et al.

Source: Climacteric. Aug2015, Vol. 18 Issue 4, p590-607. 18p.

DHEA and intracrinology at menopause, a positive choice for evolution of the human species.

Authors: Labrie, F. Labrie, C.

Source: Climacteric. Apr2013, Vol. 16 Issue 2, p205-213. 9p.

Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia.

Authors: Labrie, F. Archer, D. F. Bouchard, C. et al.

Source: Climacteric. Apr2011, Vol. 14 Issue 2, p282-288. 7p. 4 Graphs.

Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women

Authors: Labrie, F. Bélanger, A. Labrie, C. et al.

Source: Journal of Steroid Biochemistry & Molecular Biology. Oct2007, Vol. 107 Issue 1/2, p57-69. 13p.

This result is not displayed to guests.
Login for full access.

Estrogen receptor α-mediated adiposity-lowering and hypocholesterolemic actions of the selective estrogen receptor modulator acolbifene.

Authors: Lemieux, C. Phaneuf, D. Labrie, F. et al.

Source: International Journal of Obesity. Oct2005, Vol. 29 Issue 10, p1236-1244. 9p.

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy.

Authors: Labrie, F. Archer, D.F. Portman, D.

Source: Maturitas. Nov2015, Vol. 82 Issue 3, p315-316. 2p.

This result is not displayed to guests.
Login for full access.

015 Combined Data of Intravaginal Prasterone against Vulvovaginal Atrophy of Menopause.

Authors: Labrie, F. Archer, D.F. Martel, C. et al.

Source: Journal of Sexual Medicine. Jun2017 Supplement 5, Vol. 14, pe356-e356. 1p.

013 Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy.

Authors: Labrie, F. DeRogatis, L. Archer, D.F. et al.

Source: Journal of Sexual Medicine. Jun2016 Supplement, Vol. 13, pS244-S244. 1p.

Abstract: 524 LOW SERUM LEVELS OF DHEA PREDICT DEATH FROM CARDIOVASCULAR DISEASE IN OLDER MEN

Authors: Ohlsson, C Labrie, F Barrett-Connor, E et al.

Source: Atherosclerosis (Supplements). Jun2009, Vol. 10 Issue 2, pe268-e268. 1p.

SERUM STEROID LEVELS DURING 12-WEEK INTRAVAGINAL DHEA ADMINISTRATION

Authors: Labrie, F. Archer, D. Bouchard, C. et al.

Source: Maturitas. May2009 Supplement 1, Vol. 63, pS129-S130. 0p.

INTRAVAGINAL PRASTERONE (DHEA), A HIGHLY EFFICIENT AND THE ONLY PHYSIOLOGICAL TREATMENT OF VAGINAL ATROPHY

Authors: Labrie, F. Archer, D. Bouchard, C. et al.

Source: Maturitas. May2009 Supplement 1, Vol. 63, pS29-S29. 1p.

This result is not displayed to guests.
Login for full access.

Gender differences and effects of sex steroids and dehydroepiandrosterone on androgen and oestrogen α receptors in mouse sebaceous glands.

Authors: Azzi, L. El-Alfy, M. Labrie, F.

Source: British Journal of Dermatology. Jan2006, Vol. 154 Issue 1, p21-27. 7p.

Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists.

Authors: Spitz, I. M. Chertin, B. Fridmans, A. et al.

Source: Prostate Cancer & Prostatic Diseases. 2009, Vol. 12 Issue 1, p100-103. 4p. 1 Chart, 2 Graphs.